FDA Officials Criticized for Secrecy

For years, the public calendars of two top federal drug safety officials were largely blank – devoid of the required detail about their contacts with the industry they regulated.

Open government experts and lawmakers said it is only the latest example of the lack of transparency at the Food and Drug Administration and a violation of the spirit of open government. The FDA attributed it to administrative oversight.

A review by House Republican staff found the public calendars for Drs. Janet Woodcock and Steven Galson virtually empty. Woodcock is a deputy FDA commissioner and former drug chief. Galson is current drug chief.

There were just three listings for Woodcock between January 1999 and December 2006, even though she occupied two positions during that time that required her meetings to be listed: director of the center for drug evaluation and research and, later, deputy commissioner for operations. Investigators found no listings for Galson, who took over the drugs office from Woodcock on a full-time basis in July 2005.

(Original Article)